Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-02 Sale | 2024-01-04 6:05 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 2,777 | $20.09 | $55,802 | 1,212,012 (Indirect Direct) | View |
| 2023-05-15 Purchase | 2023-05-15 8:01 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 10,000 | $5.377 | $53,770 | 1,214,789 (Indirect Direct) | View |
| 2022-11-10 Sale | 2022-11-14 8:48 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 4,436 | $15.32 | $67,974 | 4,907 (Direct) | View |
| 2022-11-08 Sale | 2022-11-09 8:33 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 17,166 | $15.6 | $267,794 | 4,907 (Direct) | View |
| 2022-11-03 Sale | 2022-11-07 8:19 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 35,196 | $15.86 | $558,274 | 4,907 (Direct) | View |
| 2022-10-31 Sale | 2022-11-02 8:52 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 4,232 | $15.27 | $64,625 | 4,907 (Direct) | View |
| 2022-10-27 Sale | 2022-10-28 8:27 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 2,607 | $15.18 | $39,582 | 4,907 (Direct) | View |
| 2022-10-24 Sale | 2022-10-26 9:19 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 9,350 | $15.76 | $147,358 | 4,907 (Direct) | View |
| 2022-10-20 Sale | 2022-10-24 9:44 pm | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 21,244 | $16.47 | $349,912 | 4,907 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Option Award(A) | 2024-03-29 4:16 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 99,000 | $0 | 101,130 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-18 7:26 pm | N/A 2034-03-14 | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 297,000 | $0 | 1,509,012 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 5:36 pm | N/A 2033-02-22 | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 267,650 | $0 | 267,650 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 9:10 pm | N/A 2032-05-11 | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2022-03-29 Conversion | 2022-03-31 8:15 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 4,907 | $0 | 4,907 (Direct) | View |
Ownership | 2022-03-24 9:19 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Easom Eric Chief Executive Officer | 0 | $0 | 1,549,019 (Indirect) | View |